 9. Patients must have adequate bone marrow function ANC 1,500mm3 and platelet count of 100,000mm3, adequate liver function SGPT and SGOT 2.5 times normal, bilirubin 2 mg, and adequate renal function BUN and creatinine 1.5 times institutional normal prior to starting therapy. 